Yes, quantitative immunoglobulin levels (IgG, IgA, IgM) should absolutely be obtained in this patient.
In an adult with anemia, B12 deficiency, elevated inflammatory markers, and a faint M-band on SPEP, quantitative immunoglobulins are essential to characterize the monoclonal protein and exclude plasma cell or lymphoproliferative disorders that may be causing the clinical presentation.
Rationale for Testing
The presence of an M-band—even if faint—fundamentally changes the diagnostic approach. This patient requires a complete monoclonal protein workup, which includes:
- Quantitative immunoglobulins (IgG, IgA, IgM) to determine which immunoglobulin class is elevated and quantify the M-protein
- Serum and urine immunofixation (if not already done)
- Serum free light chain (FLC) assay with kappa/lambda ratio
- Complete blood count, calcium, creatinine, and albumin 1, 2
Why This Matters Clinically
The Anemia May Not Be Simple B12 Deficiency
While B12 deficiency can cause macrocytic anemia, the combination of:
- Persistent anemia
- Elevated ESR/CRP (suggesting systemic inflammation or malignancy)
- Monoclonal protein on SPEP
...raises concern for an underlying plasma cell disorder or lymphoplasmacytic malignancy that is causing both the anemia and the B12 deficiency 3. Recent case reports demonstrate that persistent unexplained anemia in older adults can be the presenting feature of smoldering multiple myeloma or Waldenström macroglobulinemia, identified only after extended workup including quantitative immunoglobulins 3.
Risk Stratification Depends on Immunoglobulin Type and Level
The guidelines are explicit that management differs based on:
IgG M-protein:
- If ≤15 g/L with normal FLC ratio: low-risk MGUS, bone marrow biopsy not routinely needed 2
- If >15 g/L or abnormal FLC ratio: bone marrow examination required 2
IgA M-protein:
- Bone marrow examination should be part of the diagnostic workup for all IgA M-proteins 1
- Higher risk of plasma cell infiltration (20.5% risk of ≥10% plasma cells even with M-protein ≤15 g/L, compared to 4.7% for IgG) 1
IgM M-protein:
- Bone marrow examination required for all cases 1
- CT scan of chest/abdomen/pelvis indicated to evaluate for lymphadenopathy (Waldenström macroglobulinemia) 2
Potential Confounding Factor
Be aware that elevated B12 levels can occasionally occur due to IgG-B12 or IgG-IgM-B12 immune complexes 4, 5. However, this patient has B12 deficiency, not elevation, making this less relevant—though it underscores that monoclonal proteins can have complex interactions with other laboratory values.
Algorithmic Approach
Order quantitative immunoglobulins immediately along with serum immunofixation (if not done) and serum free light chains
Based on results:
- IgG type with M-protein ≤15 g/L and normal FLC ratio: Consider observation with repeat testing in 3-6 months if no end-organ damage 2
- IgG type with M-protein >15 g/L OR abnormal FLC ratio: Proceed to bone marrow biopsy 2
- IgA or IgM type at any level: Proceed to bone marrow biopsy 1
- Any type with unexplained anemia (as in this case): Bone marrow biopsy is indicated regardless of M-protein level 2
Additional workup based on immunoglobulin type:
Critical Pitfall to Avoid
Do not attribute the anemia solely to B12 deficiency and stop the workup. The combination of anemia + M-protein + elevated inflammatory markers demands exclusion of multiple myeloma, smoldering myeloma, Waldenström macroglobulinemia, or AL amyloidosis 1, 3. Missing these diagnoses delays treatment and allows progression to end-organ damage.
The quantitative immunoglobulins are not optional—they are the foundation for determining disease type, risk stratification, and whether immediate bone marrow examination is needed 1, 2.